| First Author | Glabinski AR | Year | 1998 |
| Journal | Neuroimmunomodulation | Volume | 5 |
| Issue | 3-4 | Pages | 166-71 |
| PubMed ID | 9730682 | Mgi Jnum | J:51590 |
| Mgi Id | MGI:1321008 | Doi | 10.1159/000026333 |
| Citation | Glabinski AR, et al. (1998) Expression of chemokines RANTES, MIP-1alpha and GRO-alpha correlates with inflammation in acute experimental autoimmune encephalomyelitis. Neuroimmunomodulation 5(3-4):166-71 |
| abstractText | Experimental autoimmune encephalomyelitis (EAE) is an investigator-initiated disorder that serves as an animal model for the common human demyelinating disease multiple sclerosis. Both diseases are typified by disseminated perivascular and submeningeal cuffs in the central nervous system (CNS). It was shown recently that chemokines are integral to the pathogenesis of EAE. In the present study we analyzed the gene expression of three chemokines, RANTES, MIP-1alpha and GRO-alpha, at the onset of acute EAE, and correlated that expression with the intensity of inflammatory changes in the CNS. We showed that all three chemokines are upregulated simultaneously with symptom onset of acute EAE, and that chemokine expression correlates with the intensity of inflammation in the CNS. This consistent relationship supports the hypothesis that chemokines are relevant to leukocyte accumulation in CNS parenchyma. |
